Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial

Reichardt, P; Demetri, G; Kang, Y-K; Blay, J-Y; Joensuu, H; Maki, R; Rutkowski, P; Hohenberger, P; Gelderblom, H; Leahy, M; von Mehren, M; Schoffski, P; Blackstein, M; Le Cesne, A; Badalamenti, G; Xu, Jie; Nishida, T; Laurent, D; Kuss, I; Casali, P

Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial

Author:

Reichardt, P

Demetri, G ; Kang, Y-K ; Blay, J-Y ; Joensuu, H ; Maki, R ; Rutkowski, P ; Hohenberger, P ; Gelderblom, H ; Leahy, M ; von Mehren, M ; Schoffski, P ; Blackstein, M ; Le Cesne, A ; Badalamenti, G ; Xu, Jie ; Nishida, T ; Laurent, D ; Kuss, I ; Casali, P

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1103 Clinical Sciences, Oncology & Carcinogenesis, 3202 Clinical sciences